Shanmugam Muthusamy

Average Profitability
24.75%
Insider Buys Quantity
1
Insider Buys Sum
$138,251.50
Insider Sells Quantity
56
Insider Sells Sum
$41.35M

Insider Activity of Shanmugam Muthusamy

According to the SEC Form 4 filings, Shanmugam Muthusamy, being in a position of

  1. HEAD OF R&D, COO-NOVITIUM OPS at ANI Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 350000 shares for $21.35M,
    over all time since 2022-03-17, has bought 5000 shares for $138,252, and sold 700000 shares for $41.35M.

The largest purchase of all time was on 2022-03-17 and amounted to 5000 shares of ANI Pharmaceuticals, Inc. for $138,252.

The largest sale of all time was on 2023-08-14 and amounted to 27890 shares of ANI Pharmaceuticals, Inc. for $1.71M.

Biography of Shanmugam Muthusamy

No biography is available at this moment.

2024-07-18SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF R&D, COO-NOVITIUM OPS
2,743
0.0132%
$62.00$170,066-2.75%
2024-07-17SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF R&D, COO-NOVITIUM OPS
14,257
0.0682%
$63.16$900,472-5.26%
2024-07-16SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF R&D, COO-NOVITIUM OPS
22,000
0.103%
$64.27$1.41M-7.08%
2024-07-15SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF R&D, COO-NOVITIUM OPS
11,000
0.0508%
$63.38$697,1800%
2024-06-21SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF R&D, COO-NOVITIUM OPS
20,000
0.0866%
$58.90$1.18M+2.61%
2024-06-20SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF R&D, COO-NOVITIUM OPS
11,447
0.0503%
$59.86$685,217+0.93%
2024-06-18SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF R&D, COO-NOVITIUM OPS
10,607
0.0474%
$60.76$644,481-1.5%
2024-06-17SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF R&D, COO-NOVITIUM OPS
7,946
0.0359%
$61.41$487,964-2.97%
2024-05-20SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF R&D, COO-NOVITIUM OPS
12,855
0.0614%
$61.81$794,568-1.46%
2024-05-17SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF R&D, COO-NOVITIUM OPS
5,836
0.0269%
$62.09$362,357-0.88%
2024-05-16SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF R&D, COO-NOVITIUM OPS
16,459
0.078%
$63.84$1.05M-4.3%
2024-05-15SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF R&D, COO-NOVITIUM OPS
14,850
0.0719%
$65.86$978,021-5.89%
2024-04-19SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF R&D, COO-NOVITIUM OPS
16,809
0.0797%
$65.17$1.1M-5.97%
2024-04-18SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF R&D, COO-NOVITIUM OPS
10,423
0.05%
$64.98$677,287-4.51%
2024-04-17SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF R&D, COO-NOVITIUM OPS
9,520
0.0451%
$65.40$622,608-5.85%
2024-04-16SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF R&D, COO-NOVITIUM OPS
5,834
0.028%
$66.20$386,211-5.98%
2024-04-15SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF R&D, COO-NOVITIUM OPS
7,414
0.0352%
$66.33$491,771-6.98%
2024-03-08SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF R&D, COO-NOVITIUM OPS
10,000
0.0474%
$67.17$671,700-6.63%
2024-03-07SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF R&D, COO-NOVITIUM OPS
15,085
0.0714%
$66.35$1M-5.33%
2024-03-06SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF R&D, COO-NOVITIUM OPS
14,822
0.0727%
$65.47$970,396-4.08%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.